SEC Form 4 · accession 0001652252-16-000110
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Hertia
Officer — Executive Vice President
Period of report
Sep 9, 2016
Accepted (ET)
Sep 13, 2016 · 6:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common StockF1 | Sep 9, 2016 | S | 2,689 | $158.57 | D | 8,713 | D | |
| Bio-Rad A Common StockF2 | Sep 10, 2016 | M | 600 | $0.00 | A | 9,313 | D | |
| Bio-Rad A Common StockF2 | Sep 11, 2016 | M | 1,300 | $0.00 | A | 10,613 | D | |
| Bio-Rad A Common StockF3,F4 | Sep 12, 2016 | S | 728 | $155.0215 | D | 9,885 | D | |
| Bio-Rad A Common Stock | holding | — | — | — | 252 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF5,F6 | $0.00 | Sep 10, 2016 | M | 600 | D | — | — | Bio-Rad A Common Stock | 600 | 1,800 | D |
| Restricted Stock UnitsF5,F7 | $0.00 | Sep 11, 2016 | M | 700 | D | — | — | Bio-Rad A Common Stock | 700 | 1,400 | D |
| Restricted Stock UnitsF5,F8 | $0.00 | Sep 11, 2016 | M | 600 | D | — | — | Bio-Rad A Common Stock | 600 | 2,400 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.55 to $158.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2Shares of Class A common stock acquired on the vesting of restricted stock units.
- F3Sold by the Issuer on behalf of the Reporting Person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.0164 to $155.0314, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F6The restricted stock units vest in five equal annual installments beginning September 10, 2015.
- F7The restricted stock units vest in five equal annual installments beginning September 11, 2014.
- F8The restricted stock units vest in five equal annual installments beginning September 11, 2016.